BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) Fundamental Analysis & Valuation

FRA:BRYN • US0846707026

Current stock price

414.15 EUR
-2.55 (-0.61%)
Last:

This BRYN.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. BRYN.DE Profitability Analysis

1.1 Basic Checks

  • BRYN had positive earnings in the past year.
  • In the past year BRYN had a positive cash flow from operations.
  • BRYN had positive earnings in 4 of the past 5 years.
  • In the past 5 years BRYN always reported a positive cash flow from operatings.
BRYN.DE Yearly Net Income VS EBIT VS OCF VS FCFBRYN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20B -20B 40B 60B 80B

1.2 Ratios

  • With a decent Return On Assets value of 5.48%, BRYN is doing good in the industry, outperforming 79.31% of the companies in the same industry.
  • BRYN has a better Return On Equity (9.33%) than 63.79% of its industry peers.
  • BRYN has a Return On Invested Capital of 4.17%. This is in the better half of the industry: BRYN outperforms 60.34% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for BRYN is significantly below the industry average of 10.88%.
Industry RankSector Rank
ROA 5.48%
ROE 9.33%
ROIC 4.17%
ROA(3y)7.4%
ROA(5y)5.83%
ROE(3y)13.39%
ROE(5y)10.63%
ROIC(3y)4.29%
ROIC(5y)3.99%
BRYN.DE Yearly ROA, ROE, ROICBRYN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15

1.3 Margins

  • BRYN has a Profit Margin of 18.03%. This is in the better half of the industry: BRYN outperforms 72.41% of its industry peers.
  • BRYN's Profit Margin has been stable in the last couple of years.
  • BRYN has a Operating Margin (15.63%) which is in line with its industry peers.
  • BRYN's Operating Margin has improved in the last couple of years.
  • With a Gross Margin value of 24.75%, BRYN perfoms like the industry average, outperforming 43.10% of the companies in the same industry.
  • In the last couple of years the Gross Margin of BRYN has grown nicely.
Industry RankSector Rank
OM 15.63%
PM (TTM) 18.03%
GM 24.75%
OM growth 3Y5.77%
OM growth 5Y5.73%
PM growth 3YN/A
PM growth 5Y0.81%
GM growth 3Y5.1%
GM growth 5Y2.53%
BRYN.DE Yearly Profit, Operating, Gross MarginsBRYN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

5

2. BRYN.DE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), BRYN is creating some value.
  • BRYN has about the same amout of shares outstanding than it did 1 year ago.
  • BRYN has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for BRYN has been reduced compared to a year ago.
BRYN.DE Yearly Shares OutstandingBRYN.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500K 1M 1.5M
BRYN.DE Yearly Total Debt VS Total AssetsBRYN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200B 400B 600B 800B 1T

2.2 Solvency

  • BRYN has an Altman-Z score of 1.37. This is a bad value and indicates that BRYN is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of 1.37, BRYN perfoms like the industry average, outperforming 55.17% of the companies in the same industry.
  • The Debt to FCF ratio of BRYN is 5.15, which is a neutral value as it means it would take BRYN, 5.15 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 5.15, BRYN is in the better half of the industry, outperforming 67.24% of the companies in the same industry.
  • BRYN has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
  • With a decent Debt to Equity ratio value of 0.18, BRYN is doing good in the industry, outperforming 68.97% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 5.15
Altman-Z 1.37
ROIC/WACC1.25
WACC3.32%
BRYN.DE Yearly LT Debt VS Equity VS FCFBRYN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200B 400B 600B

2.3 Liquidity

  • A Current Ratio of 1.36 indicates that BRYN should not have too much problems paying its short term obligations.
  • BRYN has a Current ratio (1.36) which is in line with its industry peers.
  • BRYN has a Quick Ratio of 1.09. This is a normal value and indicates that BRYN is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of BRYN (1.09) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.36
Quick Ratio 1.09
BRYN.DE Yearly Current Assets VS Current LiabilitesBRYN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B

4

3. BRYN.DE Growth Analysis

3.1 Past

  • BRYN shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -6.25%.
  • Measured over the past years, BRYN shows a quite strong growth in Earnings Per Share. The EPS has been growing by 17.67% on average per year.
  • The Revenue has been growing slightly by 0.00% in the past year.
  • BRYN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.63% yearly.
EPS 1Y (TTM)-6.25%
EPS 3Y13.85%
EPS 5Y17.67%
EPS Q2Q%-29.78%
Revenue 1Y (TTM)0%
Revenue growth 3Y7.14%
Revenue growth 5Y8.63%
Sales Q2Q%-0.72%

3.2 Future

  • BRYN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.50% yearly.
  • Based on estimates for the next years, BRYN will show a small growth in Revenue. The Revenue will grow by 5.94% on average per year.
EPS Next Y7.31%
EPS Next 2Y4.96%
EPS Next 3Y4.08%
EPS Next 5Y4.5%
Revenue Next Year-4.59%
Revenue Next 2Y-0.68%
Revenue Next 3Y-0.49%
Revenue Next 5Y5.94%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BRYN.DE Yearly Revenue VS EstimatesBRYN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 100B 200B 300B 400B
BRYN.DE Yearly EPS VS EstimatesBRYN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10K 20K 30K

9

4. BRYN.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 0.02, the valuation of BRYN can be described as very cheap.
  • Based on the Price/Earnings ratio, BRYN is valued cheaper than 100.00% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 25.23. BRYN is valued rather cheaply when compared to this.
  • The Price/Forward Earnings ratio is 0.01, which indicates a rather cheap valuation of BRYN.
  • BRYN's Price/Forward Earnings ratio is rather cheap when compared to the industry. BRYN is cheaper than 100.00% of the companies in the same industry.
  • BRYN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.42.
Industry RankSector Rank
PE 0.02
Fwd PE 0.01
BRYN.DE Price Earnings VS Forward Price EarningsBRYN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BRYN indicates a rather cheap valuation: BRYN is cheaper than 93.10% of the companies listed in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of BRYN indicates a rather cheap valuation: BRYN is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 0.03
EV/EBITDA 1.04
BRYN.DE Per share dataBRYN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 100K 200K 300K 400K

4.3 Compensation for Growth

  • BRYN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • BRYN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)0
PEG (5Y)0
EPS Next 2Y4.96%
EPS Next 3Y4.08%

0

5. BRYN.DE Dividend Analysis

5.1 Amount

  • BRYN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

BRYN.DE Fundamentals: All Metrics, Ratios and Statistics

BERKSHIRE HATHAWAY INC-CL B

FRA:BRYN (3/23/2026, 5:24:46 PM)

414.15

-2.55 (-0.61%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)03-02
Earnings (Next)05-01
Inst Owners30.29%
Inst Owner ChangeN/A
Ins Owners37.74%
Ins Owner ChangeN/A
Market Cap596.38M
Revenue(TTM)371.44B
Net Income(TTM)66.97B
Analysts44
Price Target442.96 (6.96%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-5.53%
Min EPS beat(2)-15.88%
Max EPS beat(2)4.81%
EPS beat(4)2
Avg EPS beat(4)-5.16%
Min EPS beat(4)-15.88%
Max EPS beat(4)4.81%
EPS beat(8)5
Avg EPS beat(8)5.49%
EPS beat(12)8
Avg EPS beat(12)6.31%
EPS beat(16)11
Avg EPS beat(16)6.41%
Revenue beat(2)1
Avg Revenue beat(2)-0.41%
Min Revenue beat(2)-1.53%
Max Revenue beat(2)0.72%
Revenue beat(4)1
Avg Revenue beat(4)-1.81%
Min Revenue beat(4)-4.09%
Max Revenue beat(4)0.72%
Revenue beat(8)2
Avg Revenue beat(8)-1.86%
Revenue beat(12)5
Avg Revenue beat(12)-0.17%
Revenue beat(16)6
Avg Revenue beat(16)-0.79%
PT rev (1m)0.43%
PT rev (3m)-1.8%
EPS NQ rev (1m)-2.92%
EPS NQ rev (3m)-2.92%
EPS NY rev (1m)-0.01%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-3.92%
Revenue NQ rev (3m)-3.92%
Revenue NY rev (1m)-4.31%
Revenue NY rev (3m)-4.31%
Valuation
Industry RankSector Rank
PE 0.02
Fwd PE 0.01
P/S 0
P/FCF 0.03
P/OCF 0.01
P/B 0
P/tB 0
EV/EBITDA 1.04
EPS(TTM)26769.65
EY6463.76%
EPS(NY)28727.1
Fwd EY6936.4%
FCF(TTM)15050
FCFY3633.95%
OCF(TTM)27626.9
OCFY6670.75%
SpS223234.29
BVpS431161.95
TBVpS360296
PEG (NY)0
PEG (5Y)0
Graham Number509604
Profitability
Industry RankSector Rank
ROA 5.48%
ROE 9.33%
ROCE 5.14%
ROIC 4.17%
ROICexc 4.37%
ROICexgc 5.16%
OM 15.63%
PM (TTM) 18.03%
GM 24.75%
FCFM 6.74%
ROA(3y)7.4%
ROA(5y)5.83%
ROE(3y)13.39%
ROE(5y)10.63%
ROIC(3y)4.29%
ROIC(5y)3.99%
ROICexc(3y)4.49%
ROICexc(5y)4.21%
ROICexgc(3y)5.35%
ROICexgc(5y)5.06%
ROCE(3y)5.29%
ROCE(5y)4.92%
ROICexgc growth 3Y2.7%
ROICexgc growth 5Y6.05%
ROICexc growth 3Y3.93%
ROICexc growth 5Y7.05%
OM growth 3Y5.77%
OM growth 5Y5.73%
PM growth 3YN/A
PM growth 5Y0.81%
GM growth 3Y5.1%
GM growth 5Y2.53%
F-Score5
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 5.15
Debt/EBITDA 1.8
Cap/Depr 155.29%
Cap/Sales 5.63%
Interest Coverage 11.39
Cash Conversion 64.28%
Profit Quality 37.39%
Current Ratio 1.36
Quick Ratio 1.09
Altman-Z 1.37
F-Score5
WACC3.32%
ROIC/WACC1.25
Cap/Depr(3y)152.78%
Cap/Depr(5y)144.82%
Cap/Sales(3y)5.36%
Cap/Sales(5y)5.2%
Profit Quality(3y)27.13%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-6.25%
EPS 3Y13.85%
EPS 5Y17.67%
EPS Q2Q%-29.78%
EPS Next Y7.31%
EPS Next 2Y4.96%
EPS Next 3Y4.08%
EPS Next 5Y4.5%
Revenue 1Y (TTM)0%
Revenue growth 3Y7.14%
Revenue growth 5Y8.63%
Sales Q2Q%-0.72%
Revenue Next Year-4.59%
Revenue Next 2Y-0.68%
Revenue Next 3Y-0.49%
Revenue Next 5Y5.94%
EBIT growth 1Y-4.75%
EBIT growth 3Y13.32%
EBIT growth 5Y14.85%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y115.58%
FCF growth 3Y4.59%
FCF growth 5Y-1.32%
OCF growth 1Y50.26%
OCF growth 3Y7.17%
OCF growth 5Y2.94%

BERKSHIRE HATHAWAY INC-CL B / BRYN.DE Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for BERKSHIRE HATHAWAY INC-CL B?

ChartMill assigns a fundamental rating of 5 / 10 to BRYN.DE.


What is the valuation status of BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) stock?

ChartMill assigns a valuation rating of 9 / 10 to BERKSHIRE HATHAWAY INC-CL B (BRYN.DE). This can be considered as Undervalued.


What is the profitability of BRYN stock?

BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) has a profitability rating of 6 / 10.


What are the PE and PB ratios of BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) stock?

The Price/Earnings (PE) ratio for BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) is 0.02 and the Price/Book (PB) ratio is 0.


How financially healthy is BERKSHIRE HATHAWAY INC-CL B?

The financial health rating of BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) is 5 / 10.